Pacific Biosciences Of California (PACB) Net Margin (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Net Margin of 22.26% for Q1 2026, up 112455.0% year-over-year from N/an in Q1 2025, and up 75.39% quarter-over-quarter from 90.43% in Q4 2025.
Pacific Biosciences Of California (PACB) Net Margin (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Net Margin history runs 17 years deep, the most recent figure standing at 22.26% for Q1 2026.
- In Q1 2026, Net Margin rose 112455.0% year-over-year to 22.26%; the TTM figure through Mar 2026 stood at 80.34% (up 35137.0% YoY), while the FY2025 annual figure was 341.47%, down 14029.0% from the prior year.
- Net Margin for Q1 2026 stood at 22.26%, up from 90.43% in the prior quarter.
- The five-year high for Net Margin was 6.04% in Q4 2024, with the low at 1146.81% in Q1 2025.
- The 5-year median for Net Margin is 151.94% (2024), against an average of 230.57%.
- The sharpest annual moves came in 2025 and 2026: Net Margin tumbled 94537 bps in 2025, then surged 112455 bps in 2026.
- Pacific Biosciences Of California's Net Margin stood at 308.5% in 2022, then soared by 54 bps to 140.55% in 2023, then jumped by 104 bps to 6.04% in 2024, then plunged by 1596 bps to 90.43% in 2025, then jumped by 75 bps to 22.26% in 2026.
- Business Quant data shows PACB's Net Margin at 22.26% in Q1 2026, 90.43% in Q4 2025, and 98.85% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 13.47% |
| 10 | Pacific Biosciences Of California | 397.95 Mn | 161.08 Mn | 12.64 Mn | -114.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -114.70% |
| Mar 31, 2026 | -22.26% |
| Dec 31, 2025 | -90.43% |
| Sep 30, 2025 | -98.85% |
| Jun 30, 2025 | -105.44% |
| Mar 31, 2025 | -1,146.81% |
| Dec 31, 2024 | 6.04% |
| Sep 30, 2024 | -151.94% |
| Jun 30, 2024 | -481.27% |
| Mar 31, 2024 | -201.44% |
| Dec 31, 2023 | -140.55% |
| Sep 30, 2023 | -120.07% |
| Jun 30, 2023 | -146.79% |
| Mar 31, 2023 | -226.26% |
| Dec 31, 2022 | -308.50% |
| Sep 30, 2022 | -238.22% |
| Jun 30, 2022 | -201.30% |
| Mar 31, 2022 | -245.68% |
| Dec 31, 2021 | -192.48% |
| Jun 30, 2021 | -288.10% |